Health care

Sky Medical Technology wins Liverpool Echo Regional Business Award 2021

Retrieved on: 
Friday, June 18, 2021

Sky Medical Technology has partnered with clinicians across the NHS and private medical facilities to improve patient outcomes and is exploring further use cases for its technology.

Key Points: 
  • Sky Medical Technology has partnered with clinicians across the NHS and private medical facilities to improve patient outcomes and is exploring further use cases for its technology.
  • LONDON, June 18, 2021 /PRNewswire/ -- Daresbury (Cheshire) based medical technology (MedTech) company, Sky Medical Technology (Sky), has won the Innovation and Technology Award at the Liverpool Echo Regional Business Awards 2021.
  • Sky Medical Technology is addressing some of the most serious life-threatening and limiting illnesses that impact people's lives through innovative and non-invasive technology.
  • Sky Medical Technology is a highly innovative UK-based medical devices company that has developed a ground-breaking neuromuscular electrostimulation technology platform, OnPulse.

Ending Racism Partnership Panel of Health Experts Addresses Ways to Further Health Equity in Philadelphia and Society

Retrieved on: 
Friday, June 18, 2021

The timely topic of health equity kicks off the second phase of the Partnership's work, which is focused on establishing priorities for healing and rebuilding from systemic racism.

Key Points: 
  • The timely topic of health equity kicks off the second phase of the Partnership's work, which is focused on establishing priorities for healing and rebuilding from systemic racism.
  • Criminal justice, education, and housing were identified as the top three areas where survey respondents believe racism exists in Philadelphia, followed by employment, wealth, health, and arts and culture.
  • During the second panel, "An Equitable Health System," the health experts explored the work being done in the region to address equity in healthcare.
  • Dr. Mark Tyler, Pastor, Mother Bethel AME Church, and supported by a Steering Committee of 25+ leaders representing cross-sections of power in Philadelphia.

SmileFy Releases 3D Smile Design for Facially Guided In-Office Digital Treatment Planning

Retrieved on: 
Friday, June 18, 2021

MIAMI, June 18, 2021 /PRNewswire/ --SmileFy Inc. released the latestupdate of its advanced smile design software, which features 3D Smile Design asa chairside solution for dentists to create facially guided dental mock-ups in-office and in just a few minutes.

Key Points: 
  • MIAMI, June 18, 2021 /PRNewswire/ --SmileFy Inc. released the latestupdate of its advanced smile design software, which features 3D Smile Design asa chairside solution for dentists to create facially guided dental mock-ups in-office and in just a few minutes.
  • The 3D Smile Design module comes just weeks after announcing the smile design software to the cosmetic dentistry community.
  • SmileFy's 3D Smile Design makes the digital workflowsimpler and reliable so, paired with their knowledge and clinical expertise, dentistscan yield the best possible esthetic outcomes for their patients.
  • 3D Smile Design to create digital wax-up in-office in a few minutes.

Chapters Health Foundation to Host Inaugural Duck Derby in Support of Good Shepherd Hospice

Retrieved on: 
Friday, June 18, 2021

TAMPA, Fla., June 18, 2021 /PRNewswire/ --The Chapters Health Foundation, in support of Good Shepherd Hospice, today announced its plan to host the inaugural Duck Derby presented by Southern Homes .

Key Points: 
  • TAMPA, Fla., June 18, 2021 /PRNewswire/ --The Chapters Health Foundation, in support of Good Shepherd Hospice, today announced its plan to host the inaugural Duck Derby presented by Southern Homes .
  • "We couldn't be more excited about this opportunity to gather together in support of the Good Shepherd Hospice mission," said Paula Creamer, director of philanthropy for the Chapters Health Foundation in support of Good Shepherd Hospice.
  • Chapters Health Foundation is a 501(c)(3), not-for-profit organization committed to supporting Chapters Health System, a progressive leader in home health, palliative care, hospice and grief support.
  • Chapters Health Foundation also provides $1.3 million in funding for the provision of grief support across Chapters Health and more than $1 million to assist with underfunded pediatric and adult palliative care services.

Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2021

Retrieved on: 
Friday, June 18, 2021

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

Key Points: 
  • Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.
  • For further information on Taro Pharmaceutical Industries Ltd., please visit Taros website at www.taro.com .
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20210618005039/en/

Radiofrequency Ablation Devices Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 18, 2021

The "Radiofrequency Ablation Devices Market Research Report: By Component (Catheter Systems, Generators, Accessories), Application (Oncology, Cardiology, Pain Management), End User (Hospitals, Ambulatory Surgical Centers) - Global Industry Analysis and Demand" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiofrequency Ablation Devices Market Research Report: By Component (Catheter Systems, Generators, Accessories), Application (Oncology, Cardiology, Pain Management), End User (Hospitals, Ambulatory Surgical Centers) - Global Industry Analysis and Demand" report has been added to ResearchAndMarkets.com's offering.
  • The radiofrequency (RF) ablation devices market stood at $3,173.5 million in 2019, and it is projected to reach $11,080.3 million by 2030, exhibiting a 12.6% CAGR during the forecast period (2020-2030).
  • The categories under the component segment of the radiofrequency ablation devices market are catheter systems, accessories, and generators.
  • During the forecast period, the Asia-Pacific (APAC) region is expected to register the fastest growth in the global radiofrequency ablation devices market.

Insights on the Healthcare Discount Plan Global Market to 2026 - by Service, Deployment Model, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Friday, June 18, 2021

The "Global Healthcare Discount Plan Market (2021-2026) by Service, Deployment Model, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Healthcare Discount Plan Market (2021-2026) by Service, Deployment Model, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • In December 2018, Cigna launched the new Cigna Healthy Pregnancy app to help improve health and lower overall healthcare costs for pregnant women.
  • The report offers a comprehensive evaluation of the Global Healthcare Discount Plan Market.
  • A complete analysis of the market, including parent industry
    Increasing Demand for Private Health Discount Plans in Different U.S. States

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0525 Per Share

Retrieved on: 
Friday, June 18, 2021

SAN JUAN CAPISTRANO, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign group of companies, which provide skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services, today announced that it has declared a quarterly cash dividend of $0.0525 per share of Ensign common stock, payable on or before July 31, 2021, to shareholders of record as of June 30, 2021.

Key Points: 
  • SAN JUAN CAPISTRANO, Calif., June 18, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign group of companies, which provide skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services, today announced that it has declared a quarterly cash dividend of $0.0525 per share of Ensign common stock, payable on or before July 31, 2021, to shareholders of record as of June 30, 2021.
  • Ensign has been a dividend-paying company since 2002.
  • TheEnsign Group, Inc.'sindependent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 240 healthcare facilities, in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin.
  • More information about Ensign is available at http://www.ensigngroup.net .

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma

Retrieved on: 
Friday, June 18, 2021

The study is evaluating the Companys therapeutic cancer vaccine candidate BNT111 in combination with Libtayo (cemiplimab) in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.

Key Points: 
  • The study is evaluating the Companys therapeutic cancer vaccine candidate BNT111 in combination with Libtayo (cemiplimab) in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.
  • The open-label randomized trial evaluates the efficacy, tolerability, and safety of BNT111 in combination with Libtayo, an anti-PD-1 monoclonal antibody, being co-developed by Regeneron and Sanofi.
  • The trial is enrolling a total of 120 patients and will evaluate the effects of the combination as well as single agents alone.
  • This Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial ( NCT02410733 ) that demonstrated a favorable safety profile in 89 patients with advanced melanoma.

CareSpan® Upgrades Proprietary Integrated Digital Care Platform with Release of CareSpan Clinic 2.0

Retrieved on: 
Friday, June 18, 2021

The recent upgrades to the CareSpan Clinic further streamline care delivery for providers, while new features empower our Nurse Practitioners to deliver care that is customized to their patients' needs."

Key Points: 
  • The recent upgrades to the CareSpan Clinic further streamline care delivery for providers, while new features empower our Nurse Practitioners to deliver care that is customized to their patients' needs."
  • Our technology roadmap includes more advancements to our best-in-class integrated care delivery platform in the months to come.
  • For further information please visit: https://www.americanapn.com
    American MedPsych Network is a growing national group practice of primary care physicians, specialists, psychiatrists, and clinical psychologists who are delivering care using the CareSpan Clinic.
  • CareSpan is dedicated to the future of integrated digital care, using sophisticated digital diagnostic and clinical decision support tools in collaboration with primary, specialty and mental health providers to drive better outcomes with a patient-centered approach.